Trial Profile
Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia: A Study in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2022
Price :
$35
*
At a glance
- Drugs Calfactant (Primary)
- Indications Bronchopulmonary dysplasia
- Focus Therapeutic Use
- Acronyms TOLSURF
- 04 Apr 2018 Results (n=420) of secondary analysis evaluating the relationship between maternal self-reported race/ethnicity and persistent wheezing illness in former high-risk, extremely low gestational age newborns, and quantifying the contribution of socioeconomic, environmental, and biological factors published in the Journal of Pediatrics
- 16 Jan 2017 Results assessing effects on respiratory outcomes at 1 year corrected age (n=450) published in the Journal of Pediatrics
- 20 Oct 2015 Results published in the Journal of Pediatrics